Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness

NCT05903924 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

316

Enrollment

INDUSTRY

Sponsor class

Conditions

Motion Sickness

Interventions

DRUG: Tradipitant
DRUG: Placebo

Sponsor

Vanda Pharmaceuticals